Mutual of America Capital Management LLC decreased its holdings in Azenta, Inc. (NASDAQ:AZTA – Free Report) by 73.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,903 shares of the company’s stock after selling 19,535 shares during the period. Mutual of America Capital Management LLC’s holdings in Azenta were worth $345,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in AZTA. Proficio Capital Partners LLC purchased a new stake in Azenta in the 4th quarter worth $910,000. Oregon Public Employees Retirement Fund lifted its holdings in shares of Azenta by 7.0% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 10,700 shares of the company’s stock valued at $535,000 after acquiring an additional 702 shares during the last quarter. Illinois Municipal Retirement Fund bought a new stake in Azenta during the fourth quarter worth approximately $1,308,000. Y Intercept Hong Kong Ltd bought a new stake in Azenta during the fourth quarter worth approximately $1,080,000. Finally, New York State Common Retirement Fund raised its holdings in Azenta by 41.0% during the 4th quarter. New York State Common Retirement Fund now owns 265,983 shares of the company’s stock valued at $13,299,000 after buying an additional 77,409 shares during the period. Hedge funds and other institutional investors own 99.08% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts recently commented on the stock. Needham & Company LLC lifted their price target on shares of Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a research note on Thursday, February 6th. Evercore ISI raised their price target on shares of Azenta from $50.00 to $52.00 and gave the stock an “in-line” rating in a research note on Thursday, February 6th. Stephens reaffirmed an “overweight” rating and issued a $60.00 price objective on shares of Azenta in a research note on Thursday, January 2nd. Finally, TD Cowen raised shares of Azenta to a “hold” rating in a research report on Thursday, February 27th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $58.75.
Azenta Stock Up 6.3 %
AZTA opened at $43.68 on Monday. Azenta, Inc. has a 52-week low of $38.82 and a 52-week high of $65.51. The company has a market cap of $2.00 billion, a P/E ratio of -14.66 and a beta of 1.52. The firm’s 50-day moving average price is $49.26 and its 200-day moving average price is $47.38.
Azenta (NASDAQ:AZTA – Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. On average, research analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current fiscal year.
Azenta Company Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Further Reading
- Five stocks we like better than Azenta
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- The Risks of Owning Bonds
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.